Debiotech and STMicroelectronics have introduced their first evaluation prototypes of a unique miniaturized insulin-delivery pump.
The tiny device can be mounted on a disposable skin patch to provide continuous insulin infusion, enabling substantial advancements in the availability, treatment efficiency and the quality of life of diabetes patients.
The breakthrough Nanopump, which relies on microfluidic MEMS (Micro-Electro-Mechanical System) technology, has successfully passed initial testing stages and is now ready to enter volume manufacturing.
The highly miniaturized disposable insulin pump combines Debiotech's expertise in insulin delivery systems with ST's strengths in manufacturing high-volume silicon-based microfluidic devices.
The Nanopump is less than one fourth the size of existing insulin-pump devices and can be worn as a nearly invisible patch on the skin.
The companies say microfluidic technology also provides better control of the administered insulin doses, more closely mimicking the natural secretion of insulin from the pancreas, while detecting potential malfunctions of the pump to further protect patients.
Share this: 
Del.icio.us |
